A lthough some health conditions are spoken about with more nuance and understanding than in the past, inflammatory bowel ...

A three-day National Inflammatory Bowel Disease (IBD) Conference and the second roundtable meeting of the BRICS IBD Consortium, being organised by the Vizag Gut Club Association in collaboration with ...

A research team led by Junior Associate Professor Kazuo Takayama, from the Department of Cell Growth and Differentiation, ...

Although several treatment options exist in the management of Crohn's disease, a patient-centered approach is integral amid ...

Scientists have reported a major breakthrough in our understanding of inflammatory bowel disorder. It could lead to more effective treatments for conditions like Crohn's disease, a new study found.

Absci Corporation's initiation of a phase 1 study using ABS-101 for the treatment of patients with IBD expected early 2025.

Inflammatory bowel disease is a chronic condition of unknown origin characterized by severe inflammation and mucosal destruction in the intestine. There are two main forms: Crohn s disease ...

An anti-TL1A monoclonal antibody called tulisokibart may help people with moderate to severe ulcerative colitis achieve ...

Opioid use is more prevalent among individuals with vs without IBD, although not related to a psychiatric comorbidity.

Researchers sought to determine the prevalence, characteristics, management, and outcomes of difficult-to-treat IBD.

New Inflammatory Bowel Disease Testing Protocol Could Speed Up Diagnosis Apr. 16, 2024 — Patients with suspected inflammatory bowel disease (IBD) could benefit from better testing protocols that ...

The Pediatric Inflammatory Bowel Disease (IBD) Center at Johns Hopkins Children’s Center is committed to providing comprehensive and compassionate care for children with Crohn’s disease, ulcerative ...